Nasdaq Photo: Reuters Teva spin-off 89bio raises $84m in Nasdaq secondary offering

89bio's lead product candidate, BIO89-100 for the treatment of nonalcoholic steatohepatitis (NASH) is in a Phase IIa trial.

Laboratory testing for coronavirus  / Photo: Ministry of Health, PR Israeli tech collaborates on Covid-19 challenges

As Covid-19 rages, companies with solutions meet hospitals with problems on digital health community platform HealthIL.

Prof. Hezi Levi / Photo: GPO Health Ministry chief: 2,100 cases in just over 36 hours

Prof. Hezi Levi feels people do not understand the extent to which Covid-19 is spreading in Israel.

Teva Photo: Reuters Ammar Awad Levinstein's purchase of Teva's Jerusalem plant in doubt

Completion of the NIS 117 million deal has been postponed with Levinstein claiming that the land of the former pharmaceutical manufacturing plant is polluted.

Ophthalmology / Photo: Shutterstock Israeli AI eye tracking co NovaSight raises $8m

The funds will be used to advance research for the company's lazy eye treatment device and eye care products such as innovative eye tracking based active glasses for myopia control.

Naftali Bennett  / Photo: Alex Kolomoisky, Yedioth Ahronoth Bennett benefits as gov't stumbles on Covid-19

In opposition, Naftali Bennett has gained popularity with policies to combat the virus, and is unscathed from his role in the government, which opened the economy.

Israel Katz and Benjamin Netanyahu / Photo: Abir Sultan Reuters , Reuters Netanyahu, Katz present new aid program

The one-year program provides immediate aid to people on furlough and the self-employed.

Haim Ramon Cannabis co Vonetize appoints Haim Ramon chairman

The former Justice Minister and Health Minister will work 40 hours per month for a salary of NIS 15,000 and 3% of the company's share equity.

OCON Intrauterine device  / Photo: PR FemTech co OCON Healthcare wins $13m intrauterine orders

The Israeli company has developed a spherical intrauterine platform for contraception and other medical applications, aimed at treating a variety of conditions in women's health without harmful hormones or invasive procedures.

Kare Schultz  / Photo: Cadya Levy IBI: 2020 will be a turning point for Teva

IBI analyst Steven Tepper is bullish on Teva, which he describes as a buy opportunity for long-term investment.

Benjamin Netanyahu / Photo: Knesset Spokesperson Adina Walman , דוברות הכנסת From model to awful warning: How the world sees Israel

The resurgence of Covid-19 in Israel has attracted worldwide attention, and led to real consequences for Israeli travelers.

Cancer Israeli AI precision oncology co Nucleai raises $6.5m

The Tel Aviv-based company analyzes datasets of tissue images using computer vision and machine learning to model the spatial characteristics of the tumor and the patient's immune system.

Prof. Siegal Sadetzki / Photo: Eyal Izhar, Globes Israel's top public health official resigns

Prof. Siegal Sadetzki accuses the current heads of the Ministry of Health of losing direction and ignoring professional advice.

Benjamin Netanyahu / Photo: Knesset Spokesperson Adina Walman , דוברות הכנסת Israel tightens restrictions, closes halls, bars, clubs

Wedding and events halls, night clubs, bars, fitness clubs and swimming pools are to close with synagogues restricted to 19 congregants, preferably outside.

Coronavirus ventilation ward / Photo: Reuven Castro, Walla! News Israel loses Covid-19 advantage

After being one of the best to cope at the pandemic's start, Israel is now among the worst, with perhaps only days to avoid lockdown.

Covid-19 and economic downturn / Photo: Shutterstock Gov't in emergency session on coronavirus

As cases continue to rise rapidly in Israel, a limit of 20 on gatherings in any space is being considered.

Police Covid-19 enforcement  / Photo: Cadya Levy, Globes Public paying small fraction of NIS 37m virus fines

Israel Police has handed out 77,000 fines since March for violating health instructions, but only 19% of the fines have been paid.

Yuval Soiref Canzon signs cannabis CBD German distribution deal

The Israeli company's branded CBD products will reach 7,000 points-of-sale in Germany.

Amnon Shashua / Photo: Rafi Kotz, Globes Amnon Shashua: No need for another lockdown

The Intel SVP tells "Globes" that the million Israelis with underlying conditions who are endangered by Covid-19 should be given special protection.

Dr Eliav Barr "I don't care who wins, as long as we get a vaccine"

MSD executive Dr. Eliav Barr describes his company's coronavirus vaccine strategy, and possible threats to come.

Gil Kerbs / Photo: private photo AI in the kitchen

Founder Gil Kerbs tells "Globes" about Newt and its personalized nutrition app, which provides motivation as well as menus.

Kare Schultz / Photo: Cadya Levy, Globes Teva at the double

Good results, falling debt and Covid-19 have all contributed to the Israeli drugmaker's share price nearly doubling since March.

Cannabis conference  / Photo: Yossi Biron "Cannabis exports were seen as election gimmick"

Former Prime Minister Ehud Olmert, a consultant to medical cannabis firm Univo, regrets the delay on export permits.

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018